Free Trial

Femasys (FEMY) Competitors

Femasys logo
$0.70 -0.04 (-5.67%)
Closing price 04:00 PM Eastern
Extended Trading
$0.63 -0.08 (-10.68%)
As of 05:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FEMY vs. SLNO, EDAP, PSTV, GUTS, ZJYL, LUNG, QTI, DXR, ICCM, and MDAI

Should you be buying Femasys stock or one of its competitors? The main competitors of Femasys include Soleno Therapeutics (SLNO), EDAP TMS (EDAP), Plus Therapeutics (PSTV), Fractyl Health (GUTS), Jin Medical International (ZJYL), Pulmonx (LUNG), QT Imaging (QTI), Daxor (DXR), IceCure Medical (ICCM), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.

Femasys vs. Its Competitors

Soleno Therapeutics (NASDAQ:SLNO) and Femasys (NASDAQ:FEMY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Soleno Therapeutics has a net margin of 0.00% compared to Femasys' net margin of -1,113.72%. Soleno Therapeutics' return on equity of -73.74% beat Femasys' return on equity.

Company Net Margins Return on Equity Return on Assets
Soleno TherapeuticsN/A -73.74% -56.67%
Femasys -1,113.72%-713.74%-152.60%

In the previous week, Soleno Therapeutics had 10 more articles in the media than Femasys. MarketBeat recorded 12 mentions for Soleno Therapeutics and 2 mentions for Femasys. Femasys' average media sentiment score of 0.48 beat Soleno Therapeutics' score of 0.38 indicating that Femasys is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Soleno Therapeutics
3 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Femasys
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Soleno Therapeutics presently has a consensus target price of $115.92, indicating a potential upside of 77.05%. Femasys has a consensus target price of $7.33, indicating a potential upside of 943.00%. Given Femasys' higher possible upside, analysts plainly believe Femasys is more favorable than Soleno Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Soleno Therapeutics
1 Sell rating(s)
0 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.93
Femasys
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Femasys has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Femasys, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Soleno TherapeuticsN/AN/A-$175.85M-$4.14-15.81
Femasys$1.63M14.05-$18.82M-$0.86-0.82

Soleno Therapeutics has a beta of -2.75, meaning that its stock price is 375% less volatile than the S&P 500. Comparatively, Femasys has a beta of -2.64, meaning that its stock price is 364% less volatile than the S&P 500.

97.4% of Soleno Therapeutics shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 6.4% of Soleno Therapeutics shares are owned by insiders. Comparatively, 11.5% of Femasys shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Soleno Therapeutics and Femasys tied by winning 8 of the 16 factors compared between the two stocks.

Get Femasys News Delivered to You Automatically

Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FEMY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FEMY vs. The Competition

MetricFemasysMED IndustryMedical SectorNASDAQ Exchange
Market Cap$22.91M$3.42B$6.09B$10.54B
Dividend YieldN/A2.29%5.73%4.78%
P/E Ratio-0.8222.5884.6327.10
Price / Sales14.05483.04606.05131.34
Price / CashN/A46.9737.8662.13
Price / Book7.0310.4112.246.58
Net Income-$18.82M-$52.47M$3.32B$276.75M
7 Day Performance14.79%2.30%0.76%0.91%
1 Month Performance97.11%14.45%8.03%4.18%
1 Year Performance-42.37%12.90%71.13%35.42%

Femasys Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FEMY
Femasys
2.8585 of 5 stars
$0.70
-5.7%
$7.33
+943.0%
-39.4%$22.91M$1.63M-0.8230News Coverage
High Trading Volume
SLNO
Soleno Therapeutics
4.1448 of 5 stars
$64.27
+0.8%
$115.92
+80.4%
+24.8%$3.39BN/A-15.5230
EDAP
EDAP TMS
3.0535 of 5 stars
$2.09
+1.0%
$8.50
+306.7%
-11.4%$77.40M$69.18M-3.43230Short Interest ↓
PSTV
Plus Therapeutics
3.205 of 5 stars
$0.68
-2.9%
$8.00
+1,081.5%
-57.1%$69.22M$5.82M-0.3020Short Interest ↑
Gap Down
GUTS
Fractyl Health
2.6402 of 5 stars
$1.34
flat
$6.90
+414.9%
-48.6%$67.39M$90K-0.65102Short Interest ↑
ZJYL
Jin Medical International
N/A$0.41
-3.1%
N/A-85.4%$66.08M$23.50M0.00245Short Interest ↑
Gap Down
LUNG
Pulmonx
3.9063 of 5 stars
$1.59
+0.6%
$7.66
+382.0%
-76.9%$64.38M$83.79M-1.11250
QTI
QT Imaging
N/A$2.25
+0.9%
N/A+237.5%$61.05M$4.00M0.00N/A
DXR
Daxor
3.8032 of 5 stars
$12.88
+2.1%
$25.00
+94.1%
+42.2%$60.99MN/A0.0037Positive News
ICCM
IceCure Medical
2.5857 of 5 stars
$0.84
-3.1%
$2.64
+212.3%
+52.8%$59.85M$3.29M-5.2760
MDAI
Spectral AI
2.1455 of 5 stars
$2.21
-0.9%
$3.50
+58.4%
+90.7%$59.61M$29.58M-3.2083Gap Up

Related Companies and Tools


This page (NASDAQ:FEMY) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners